Redpoint Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $1.76M | Sell |
2,549
-574
| -18% | -$395K | 0.26% | 93 |
|
2022
Q2 | $1.85M | Hold |
3,123
| – | – | 0.22% | 108 |
|
2022
Q1 | $2.18M | Sell |
3,123
-48
| -2% | -$33.5K | 0.22% | 105 |
|
2021
Q4 | $2M | Buy |
3,171
+110
| +4% | +$69.5K | 0.16% | 152 |
|
2021
Q3 | $1.85M | Sell |
3,061
-188
| -6% | -$114K | 0.16% | 157 |
|
2021
Q2 | $1.82M | Sell |
3,249
-264
| -8% | -$147K | 0.15% | 169 |
|
2021
Q1 | $1.66M | Buy |
3,513
+200
| +6% | +$94.6K | 0.14% | 171 |
|
2020
Q4 | $1.6M | Buy |
3,313
+781
| +31% | +$377K | 0.16% | 152 |
|
2020
Q3 | $1.42M | Sell |
2,532
-3,230
| -56% | -$1.81M | 0.15% | 156 |
|
2020
Q2 | $3.59M | Sell |
5,762
-332
| -5% | -$207K | 0.2% | 116 |
|
2020
Q1 | $2.98M | Hold |
6,094
| – | – | 0.19% | 133 |
|
2019
Q4 | $2.29M | Hold |
6,094
| – | – | 0.11% | 234 |
|
2019
Q3 | $1.69M | Hold |
6,094
| – | – | 0.09% | 287 |
|
2019
Q2 | $1.91M | Sell |
6,094
-879
| -13% | -$275K | 0.1% | 259 |
|
2019
Q1 | $2.86M | Buy |
6,973
+1,317
| +23% | +$541K | 0.14% | 181 |
|
2018
Q4 | $2.11M | Hold |
5,656
| – | – | 0.12% | 217 |
|
2018
Q3 | $2.29M | Hold |
5,656
| – | – | 0.12% | 221 |
|
2018
Q2 | $1.95M | Hold |
5,656
| – | – | 0.11% | 238 |
|
2018
Q1 | $1.95M | Hold |
5,656
| – | – | 0.11% | 239 |
|
2017
Q4 | $2.13M | Buy |
+5,656
| New | +$2.13M | 0.12% | 231 |
|